@Davriellelouna@lemmy.world to News@lemmy.world • 3 days ago‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comexternal-linkmessage-square59fedilinkarrow-up1553arrow-down13cross-posted to: globalnews@lemmy.zip
arrow-up1550arrow-down1external-link‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.com@Davriellelouna@lemmy.world to News@lemmy.world • 3 days agomessage-square59fedilinkcross-posted to: globalnews@lemmy.zip
minus-square@gravitas_deficiency@sh.itjust.workslinkfedilinkEnglish80•3 days agoPharma C-suite: that doesn’t sound very profitable I fucking wish I was kidding
minus-square@jonne@infosec.publinkfedilink1•3 days agoI mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
minus-square@jeffw@lemmy.worldMlinkfedilink13•3 days ago Pill You could read the article before you comment lol
Pharma C-suite:
I fucking wish I was kidding
“But how does this expand shareholder value”
I mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
You could read the article before you comment lol
You caught me!